-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, national cancer data from theJACCshowed that only 0.8% of all heart tumors are primary malignancies88.5% of these primary malignancies were sarcoma, the majority of which were hemanagiomas (40.4% of all primary malignancies)The 30-day, 1-year and 5-year survival rates of patients with primary heart malignancies were 81.2%, 45.3% and 11.5%, respectivelynearly 60% (59.2%) of patients with primary malignant neoplasms received surgery, of which 57.7% underwent chemotherapy, radiotherapy or radiotherapy at the same timenearly 30 percent (29.4 percent) of patients who underwent surgery alone died within 90 daysonly 26% of patients undergoing surgery had a complete excision (R0) stateThe survival rate of these patients with clean cut edge was significantly higher than in patients who were still positive for cut edgeThe long-term survival rate of patients who underwent surgerywas significantly higher than that of those who had not been operated onIn addition, in patients with stage III lesions, the survival rate was higher among patients who received chemotherapy during the perioperative periodreview experts point out that the study shows that most patients are younger (on average, 53 years old) and need to improve treatment for primary malignancies of the heartFor these patients, the first step is to improve the surgical treatment rate, and try to achieve R0 excisionIf the tumor cannot be fully removed, multidisciplinary treatment strategies are needed, and postoperative chemotherapy or radiotherapy may help improve cure rates and improve patient prognosisthe study was included in the 2004-2016 U.SNational Cancer Database in all physical heart tumor patients, a total of about 100,000 cases of heart tumors were confirmed, of which 826 (0.8%) were primary malignancies, and eventually 747 patients, with an average age of 53 years and 47.5 percent of women136 patients with primary heart cancer were not treated, 113 were undergoing chemotherapy only, and 20 were only radiotherapySource:[1] Long-Term Outcomes of Primary Cardiac Malignancies Multi-Institutional Results From the National Cancer DatabaseJ Am Coll Cardiol, 2020, 75 (18): 2338-2347Primary Cardiac Malignances: The Need for a MMDad and the Role of The Cardio-SistJ Am Coll Cardiol, 2020, 75 (18)DOI: 10.1016/j.jacc.2020.03.046Author: Zhu Zhu Source: China Circulation Journal